- UAB Master's Degree (Continuing Education)
- Code: 5193/1
- 1st edition
- Modality: Online
- Credits: 120 ECTS
- Start date: 24/09/2025
- Finish date: 12/07/2027
- Places: 50
- Orientation: Academic
- Teaching language: English
- Location: online
The Lifelong Learning Master's in Pharmacovigilance and Pharmacoepidemiology has been designed by a unique consortium of universities, regulatory agencies, and pharmaceutical companies. This distinctive network has brought together and invited top experts from the global industry, contract research organizations (CROs), health authorities, professional societies, and media outlets to broaden understanding, highlight cultural specificities, and thus meet the needs of the job market.
The program has been structured into flexible modules to facilitate access and academic progression for individuals with limited time availability, such as healthcare professionals.
All courses are delivered online and in English, allowing students to access learning materials and activities anytime and from anywhere.
The Lifelong Learning Master's in Pharmacovigilance and Pharmacoepidemiology offers a Master's degree jointly awarded by Eu2P academic partners and recognized by all Eu2P industrial and regulatory partners.
The existence of national pharmacovigilance programs, aimed at investigating and early detection of serious adverse effects in populations exposed to new medicines, requires trained and up-to-date specialists. These programs (regional in Spain and in countries such as France or the United Kingdom) need professionals with expertise in this field.
Pharmaceutical Industry
Each pharmaceutical company is legally required to have a pharmacovigilance department, staffed with at least one specialist who acts as a liaison with the national pharmacovigilance system or the corresponding supranational authority. These departments must periodically produce safety reports on all products marketed by the company.
Public and Private Healthcare Systems
Due to its relevance and the personal and social consequences of drug toxicity, hospital and primary care physicians and pharmacists may be interested in specializing in these disciplines. Moreover, such expertise may be required in cases involving legal implications of medical acts or when there is a need to communicate the risks associated with the use of a medicine to large populations through conventional media channels.
The program has been structured into flexible modules to facilitate access and academic progression for individuals with limited time availability, such as healthcare professionals.
All courses are delivered online and in English, allowing students to access learning materials and activities anytime and from anywhere.
The Lifelong Learning Master's in Pharmacovigilance and Pharmacoepidemiology offers a Master's degree jointly awarded by Eu2P academic partners and recognized by all Eu2P industrial and regulatory partners.
Career opportunities
Regulatory Agencies and Other InstitutionsThe existence of national pharmacovigilance programs, aimed at investigating and early detection of serious adverse effects in populations exposed to new medicines, requires trained and up-to-date specialists. These programs (regional in Spain and in countries such as France or the United Kingdom) need professionals with expertise in this field.
Pharmaceutical Industry
Each pharmaceutical company is legally required to have a pharmacovigilance department, staffed with at least one specialist who acts as a liaison with the national pharmacovigilance system or the corresponding supranational authority. These departments must periodically produce safety reports on all products marketed by the company.
Public and Private Healthcare Systems
Due to its relevance and the personal and social consequences of drug toxicity, hospital and primary care physicians and pharmacists may be interested in specializing in these disciplines. Moreover, such expertise may be required in cases involving legal implications of medical acts or when there is a need to communicate the risks associated with the use of a medicine to large populations through conventional media channels.
Scholarships and financial aid
Chek all the information on the possibilities for grants and scholarships in the page for UAB financial aids, grants and calls.
Interuniversity
Other institutions
Altres organismes
Coordinating centres
Departamento de Farmacología, Terapéutica y Toxicología
Collaborating centres
Université de Bordeaux (França)
Erasmus Universitair Medisch Centrum Rotterdam
Universitá degli Studi della Campania Luigi Vanvitelli
University of Hertfordshire Higher Education Corporation
.
Unversiteit Utrecht
Contact
Maria Antonieta Agusti Escasany
Phone: 93 489 41 05